The Food and Drug Administration has approved a supplemental new drug application for Pliaglis (lidocaine 7 percent, tetracaine 7 percent), a topical anesthetic cream.
Breast Care for Pregnant and Lactating Patients
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Improve Patient Outcomes With Better Language Access
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Recent Povorcitinib 2b Study Shows Improved Repigmentation
Self-Esteem in Males with Alopecia Improved by Hair Transplantation